共 332 条
[1]
Burge R(2001)Osteoporosis prevention, diagnosis, and therapy JAMA 285 785-795
[2]
Dawson-Hughes B(2007)Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 465-475
[3]
Solomon DH(1990)Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group JAMA 263 665-668
[4]
Wong JB(2003)BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures J Bone Miner Res 18 1947-1954
[5]
King A(1998)Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability J Bone Miner Res 13 1124-1133
[6]
Tosteson A(2017)Bone turnover markers: use in fracture prediction J Clin Densitom 20 346-352
[7]
Cummings SR(2018)Diagnosis of endocrine disease: bone turnover markers: are they clinically useful? Eur J Endocrinol 178 R19-R31
[8]
Black DM(2011)Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards Osteoporos Int 22 391-420
[9]
Nevitt MC(2012)National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges Osteoporos Int 23 2425-2433
[10]
Browner WS(1996)Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study Bone 18 487-488